Provided by Tiger Fintech (Singapore) Pte. Ltd.

Virpax Pharmaceuticals, Inc.

0.2700
-0.0050-1.82%
Volume:10.75K
Turnover:2.97K
Market Cap:335.48K
PE:0.00
High:0.2998
Open:0.2750
Low:0.2700
Close:0.2750
Loading ...

Analysts Conflicted on These Healthcare Names: Clearside Biomedical (CLSD) and Virpax Pharmaceuticals (VRPX)

TIPRANKS
·
07 Mar

Virpax’s NES100 to be Presented at The Society of Toxicology by NCATS

Business Wire
·
06 Mar

Virpax Reports Positive Results in Human Study for Its Molecular Envelope Technology

THOMSON REUTERS
·
28 Feb

Virpax Reports Positive Results in Human Study for its Molecular Envelope Technology

Business Wire
·
28 Feb

Penny Stock Virpax Pharmaceuticals Surges On US Army-Performed Preclinical Study For Pain Candidate

Benzinga
·
15 Feb

US Futures Modestly Lower as Investors Await Retail Sales, Industrial Production Data

MT Newswires Live
·
14 Feb

BRIEF-Virpax Confirms Positive Results With Us Army With Probudur™ For Combat Care Study

Reuters
·
14 Feb

Virpax Confirms Positive Results With US Army With Probudur™ for Combat Care Study

THOMSON REUTERS
·
14 Feb

Virpax Pharmaceuticals Appoints Charn Deol as Independent Director

TIPRANKS
·
07 Feb

Virpax Pharmaceuticals Board Member Jay Panis Resigns

TIPRANKS
·
05 Feb

Virpax Pharmaceuticals Raises $6M and Signs Investor Agreements

TIPRANKS
·
31 Jan

Spartan Capital Securities Serves as Sole Placement Agent in Virpax Pharmaceuticals’ $6 Million Follow-On Offering

GlobeNewswire
·
31 Jan

Virpax Pharmaceuticals, Inc. Announces Closing of $6.0 Million Public Offering of Common Stock and Pre-Funded Warrants

THOMSON REUTERS
·
30 Jan

Virpax Pharmaceuticals, Inc. Announces Closing of $6.0 Million Public Offering of Common Stock and Pre-Funded Warrants

Business Wire
·
30 Jan

Virpax Pharmaceuticals, Inc. Announces Pricing of $6 Million Public Offering of Common Stock and Pre-Funded Warrants

THOMSON REUTERS
·
28 Jan

Virpax Pharmaceuticals, Inc. Announces Pricing of $6 Million Public Offering of Common Stock and Pre-Funded Warrants

Business Wire
·
28 Jan

Virpax Pharmaceuticals Inc - Stockholders Approve Reverse Stock Split at 1-for-2 to 1-for-240

THOMSON REUTERS
·
16 Jan

Virpax Updates Executive Agreements for Legal Compliance

TIPRANKS
·
31 Dec 2024

Virpax Pharmaceuticals Welcomes Jay Panis to Board

TIPRANKS
·
19 Dec 2024

Virpax Pharmaceuticals Announces Board Member Resignation

TIPRANKS
·
14 Dec 2024